CDC Logo Tuberculosis Information CD-ROM   Image of people
     
jump over main navigation bar to content area
Home
TB Guidelines
Surveillance Reports
Slide Sets
TB-Related MMWRs and Reports
Education/Training Materials
Newsletters
Ordering Information
Help

 

U.S. Department of Health and Human Services

  

TB Guidelines

2003

Update: Adverse Event Data and Revised American Thoracic Society/CDC Recommendations Against the Use of Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis Infection - MMWR 2003; 52 (No. 31)
www.cdc.gov/mmwr/preview/mmwrhtml/mm5231a4.htm

 PDF
Treatment of Tuberculosis - MMWR 2003; 52 (No. RR-11)
www.cdc.gov/mmwr/preview/mmwrhtml/rr5211a1.htm
PDF
 

» Errata: Treatment of Tuberculosis - MMWR 2005; 52 (RR-11)
www.cdc.gov/mmwr/preview/mmwrhtml/mm5351a5.htm

PDF
Guidelines for Environmental Infection Control in Health-Care Facilities - MMWR 2003; 52 (No. RR-10)
www.cdc.gov/mmwr/preview/mmwrhtml/rr5210a1.htm
PDF
Timing of Tuberculosis Screening and Smallpox Vaccination - Recommendations for Using Smallpox Vaccine in a Pre-Event Vaccination Program - MMWR 2003; 52 (No. RR-7)
www.cdc.gov/mmwr/preview/mmwrhtml/rr5207a1.htm
PDF

Archived TB Guidelines

The documents listed below are historical, archived information. The information contained in these documents, while accurate at the time of release, may not be the most current available.

Guidelines for Using the QuantiFERON®-TB Test for Diagnosing Latent Mycobacterium tuberculosis Infection - MMWR 2003; 52 (RR-2); 15-18
www.cdc.gov/mmwr/preview/mmwrhtml/rr5202a2.htm
PDF

 

 


Released October 2008
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination - http://www.cdc.gov/tb

Please send comments/suggestions/requests to: hsttbwebteam@cdc.gov, or to
CDC/Division of Tuberculosis Elimination
Communications, Education, and Behavioral Studies Branch
1600 Clifton Rd., NE - Mailstop E-10, Atlanta, GA 30333